Pulmonary diseases caused by non-tuberculous mycobacteria (NTM) are emerging infectious diseases. Following publication of the management guidelines for NTM pulmonary diseases by the ATS/IDSA in 2007, ATS/ERS/ESCMID/IDSA have agreed to write a revision of these guidelines together with representatives of all four societies. The novel international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases provide up-to-date evidence based recommendations that will be useful for all clinicians caring for patients with NTM pulmonary diseases.
We will critically discuss the new evidence-based recommendations for the management of patients with NTM pulmonary diseases. Colleagues attending the webinar will become familiar with the current concepts for the treatment of NTM pulmonary diseases including important changes compared to the former ATS/IDSA management guideline from 2007.
This webinar will be an expert interview.
- When is infection a disease?
- Diagnosis of NTM-PD and the value of drug susceptibility testing.
- Which are the most important clinically relevant NTMs?
- General principles for the treatment of NTM pulmonary diseases.
- Daily or intermittend therapy of NTM- pulmonary diseases?
- The role of injectable agents, fluoroquinolones and clofazimine for the treatment of NTM- pulmonary diseases
- The role of surgery for the treatment of NTM- pulmonary diseases
- How should treatment for NTM- pulmonary diseases be monitored?
- What is the optimal duration of therapy of NTM- pulmonary diseases?
- Can treatment recommendations for less common NTM- pulmonary diseases be offered?
Following this webinar, participants will be able to:
- Discuss the management of NTM pulmonary diseases based on the novel international (ATS/ERS/ESCMID/IDSA) guidelines
What is a webinar?
The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises 45-minute lecture followed by a 15-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls. Your answers are not evaluated but participation is mandatory to obtain the CME credits.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
Log in guidelines
To attend the webinar you will need to log in to an Adobe Connect platform. We will send you related login information one week before the webinar is due to commence.
In order to benefit from this live experience we advise that you ensure that your equipment is compatible with the technical specifications listed here:
It is also recommended that you perform a system test.